Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Biopsychosoc Med ; 15(1): 9, 2021 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-34001197

RESUMEN

BACKGROUND: Autism spectrum disorder (ASD) and feeding and eating disorders (FEDs) such as anorexia nervosa (AN) are strongly linked as evidenced by frequent comorbidity and overlapping traits. However, eating and social behaviors are shaped by culture, so it is critical to examine these associations in different populations. Moreover, FEDs are heterogeneous, and there has been no examination of autistic traits in avoidant/restrictive food intake disorder (ARFID). METHODS: Therefore, we investigated the prevalence of ASD and autistic traits among Japanese children with AN (n = 92) or ARFID (n = 32) from a prospective multicenter cohort study using the Autism Spectrum Quotient Children's version (AQC) and Children's Eating Attitudes Test (ChEAT26). RESULTS: ASD prevalence was high in both AN and ARFID (16.3 and 12.5%, respectively). The AN group exhibited significantly higher scores on all AQC subscales than an age-matched healthy control (HC) group, but there were no significant correlations between AQC scores and ChEAT26 scores. In the AFRID group, AQC scores did not differ from HCs, but significant correlations were found between total AQC and ChEAT26 scores and between several AQC and ChEAT26 subscales. CONCLUSIONS: Both the AN and ARFID groups had high prevalence rates of ASD. The AN group showed a significantly higher degree of autistic traits than the HC group; however, no difference was found between the ARFID and HC groups. Clinicians need to be aware of these rates when working with children with ED.

2.
Biopsychosoc Med ; 13: 21, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31528200

RESUMEN

We developed and validated a childhood eating disorder outcome scale based on outcomes associated with body mass index standard deviation score (BMI-SDS). This prospective observational study included 131 children with eating disorders (aged 5-15 years). Participants' outcomes scales were completed at the first visit and at 1, 3, 6, and 12 months. The scale evaluated 12 outcomes: body weight change (BW), eating attitude (EA), fear of being fat (FF), body image distortion (BD), menstruation (ME), perceived physical condition (PC), attending school (AS), disease recognition by school (RS), family function (FA), disease recognition by parent (RP), social adaptation (SA), and relationships with friends (RF). Responses to all items were on a four-point Likert scale. Exploratory factor analysis was used to determine the number of factors based on the 12 outcomes. The relation between outcome scale scores and BMI-SDS over the 12-month follow-up period was analyzed. Two types of factors were extracted: disease-specific factors (EA, FF, BD) and biopsychosocial factors (BW, PC, AS, FA, SA, RF). Three items (ME, RS, RP) were excluded because they showed no significant loading effect. There was a significant negative correlation between the outcome scale and BMI-SDS, and changes in outcome scale scores from baseline to 12 months were significantly associated with improvement in BMI-SDS. We developed a childhood eating disorder outcome scale characterized by disease-specific and biopsychosocial factors. Biopsychosocial management combined with a therapeutic approach for disease-specific symptoms may support body weight recovery for children with eating disorders.

3.
J Autism Dev Disord ; 48(5): 1483-1491, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29185167

RESUMEN

Association of congenital cytomegalovirus (CMV) infection with autism spectral disorder (ASD) has been suggested since 1980s. Despite the observed association, its role as a risk factor for ASD remains to be defined. In the present review, we systematically evaluated the available evidence associating congenital CMV infection with ASD using PubMed, Web of Science, Cochrane Library, and Embase databases. Any studies on children with CMV infection and ASD were evaluated for eligibility and three observational studies were included in meta-analysis. Although a high prevalence of congenital CMV infection in ASD cases (OR 11.31, 95% CI 3.07-41.66) was indicated, too few events (0-2 events) in all included studies imposed serious limitations. There is urgent need for further studies to clarify this issue.


Asunto(s)
Trastorno del Espectro Autista/diagnóstico , Trastorno del Espectro Autista/epidemiología , Infecciones por Citomegalovirus/diagnóstico , Infecciones por Citomegalovirus/epidemiología , Trastorno del Espectro Autista/virología , Niño , Femenino , Humanos , Masculino , Estudios Observacionales como Asunto/métodos , Prevalencia , Factores de Riesgo
4.
Kobe J Med Sci ; 61(1): E19-26, 2015 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-25868610

RESUMEN

BACKGROUND: Attention Deficit/Hyperactivity Disorder (ADHD) is a common neurobehavioral problem in children throughout the world. The Stroop test has been widely used for the evaluation of ADHD symptoms. However, the age-related change of the Stroop test results has not been fully clarified until now. METHODS: Sixty-five ADHD and 70 age-matched control children aged 6-13 years were enrolled in this study. ADHD was diagnosed based on DSM-IV criteria. We examined the completion time and error rates of the Congruent Stroop test (CST) and Incongruent Stroop test (IST) in ADHD and control children. RESULTS: No significant difference was observed in the completion time for CST or IST between the ADHD and control children at 6-9 years old. However, ADHD children at 10-13 years old showed significantly delayed completion time for the CST and IST compared with controls of the same age. As for the error rates of the CST and IST, ADHD and control children at 6-9 years old showed no difference. However, error rates of CST and IST in the ADHD children at 10-13 years were significantly higher than those of control of the same age. CONCLUSIONS: Age may influence the results of Stroop test in ADHD children. For the ages of 10-13 years old, the Stroop test clearly separates ADHD children from control children, suggesting that it may be a useful screening tool for ADHD among preadolescent children.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Test de Stroop/estadística & datos numéricos , Adolescente , Factores de Edad , Estudios de Casos y Controles , Niño , Femenino , Humanos , Pruebas de Inteligencia/estadística & datos numéricos , Masculino
5.
Kobe J Med Sci ; 56(1): E12-7, 2010 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-21063141

RESUMEN

Attention-deficit/hyperactivity disorder (AD/HD) and pervasive developmental disorder (PDD) must be differentiated because the respective treatments are different. However, they are difficult to distinguish because they often show similar symptoms. At our hospital, we have the rearer of a patient answer both the ADHD Rating Scale-IV (ADHD-RS) and the Autism Spectrum Screening Questionnaire (ASSQ), and use the results as an aid for the diagnosis of AD/HD or PDD. These results were compared with reference to PDD and AD/HD for an examination of the features of the two disorders. The subjects of our study were 45 children with AD/HD and 77 children with PDD. ADHD-RS score was significantly higher for AD/HD than PDD, but the total ASSQ score was significantly higher for PDD than AD/HD. Furthermore, for the inattention subscale of ADHD-RS, both total score and number of high-score items were significantly higher for AD/HD than PDD. As for the ASSQ score for PDD, it was significantly higher than for AD/HD in the domains of repetitive behavior, social interaction, and communication problems. In addition, PDD features many high-score items in the social interaction domain. We thought that these results about both ADHD-RS and ASSQ were useful for the differentiation of AD/HD or PDD.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastornos Generalizados del Desarrollo Infantil/diagnóstico , Atención , Trastorno por Déficit de Atención con Hiperactividad/clasificación , Trastorno por Déficit de Atención con Hiperactividad/psicología , Niño , Conducta Infantil , Trastornos Generalizados del Desarrollo Infantil/psicología , Comunicación , Diagnóstico Diferencial , Femenino , Humanos , Relaciones Interpersonales , Masculino , Encuestas y Cuestionarios
6.
No To Hattatsu ; 38(3): 177-81, 2006 May.
Artículo en Japonés | MEDLINE | ID: mdl-16715930

RESUMEN

The purpose of this study is to clear up the difference between Asperger's disorder (AS) and high functioning autism (HFA) with a newly developed test, the metaphor and sarcasm scenario test (MSST) can be used to distinguish pervasive developmental disorder (PDD) from attention deficit/hyperactivity disorders (AD/HD). So 66 AS children, 20 HFA children and 37 AD/HD children were selected, compared the profiles of score on the MSST. The results showed that the inability to understand sarcastic situation was specific to group with AS, both group with HFA and AD/HD were differ little to understand between metaphor and sarcasm. In this study suggest differences in situational recognition among the PDD subtypes, the clinical symptoms of PDD reflects characteristics of AS.


Asunto(s)
Síndrome de Asperger/diagnóstico , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno Autístico/diagnóstico , Pruebas Neuropsicológicas , Pruebas Psicológicas , Reconocimiento en Psicología , Adolescente , Síndrome de Asperger/psicología , Trastorno por Déficit de Atención con Hiperactividad/psicología , Trastorno Autístico/psicología , Niño , Femenino , Humanos , Masculino , Desempeño Psicomotor/fisiología , Percepción Social
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...